---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-029513"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2025-12-30T23:59:59+00:00"
generated_at: "2026-05-16T12:00:17.138271+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics files 1-for-30 reverse stock split to regain Nasdaq minimum bid price compliance

## Summary
- Reverse stock split ratio set at 1-for-30; effective January 2, 2026 at 12:01 a.m. ET.
- Approximately 2,095,031 shares outstanding post-split; new CUSIP 189763204; ticker CODX unchanged.
- Fractional shares rounded up to next whole share; no fractional shares issued.
- Split intended to enable compliance with Nasdaq $1.00 minimum bid price listing requirement.
- Board approved ratio on Dec 29, 2025; stockholders authorized up to 1-for-30 at Dec 5 special meeting.

## SEC filing metadata
- accession: 0001493152-25-029513
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2025-12-30T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315225029513/0001493152-25-029513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315225029513/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-029513
- JSON: https://secwatch.observer/filing/0001493152-25-029513.json
- Plain text: https://secwatch.observer/filing/0001493152-25-029513.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.